TETRAPHASE PHARMACEUTICALS INC Defined Contribution Plan, Cost
TETRAPHASE PHARMACEUTICALS INC reported Defined Contribution Plan, Cost of $500.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2020-03-12
- TETRAPHASE PHARMACEUTICALS INC defined contribution plan, cost for fiscal 2019 was $500.00K, a 25.00% increase from fiscal 2018.
- TETRAPHASE PHARMACEUTICALS INC defined contribution plan, cost for fiscal 2018 was $400.00K, a 12.99% increase from fiscal 2017.
- TETRAPHASE PHARMACEUTICALS INC defined contribution plan, cost for fiscal 2017 was $354.00K, a 13.83% increase from fiscal 2016.
- TETRAPHASE PHARMACEUTICALS INC defined contribution plan, cost for fiscal 2016 was $311.00K, a 19.16% increase from fiscal 2015.
| Period end | Defined Contribution Plan, Cost 12 month | Defined Contribution Plan, Cost 12 month as first filed |
|---|---|---|
| 2019-12-31 | $500.00K 10-K · filed 2020-03-12 | |
| 2018-12-31 | $400.00K 10-K · filed 2020-03-12 | $402.00K 10-K · filed 2019-03-15 |
| 2017-12-31 | $354.00K 10-K · filed 2019-03-15 | |
| 2016-12-31 | $311.00K 10-K · filed 2018-03-06 | |
| 2015-12-31 | $261.00K 10-K · filed 2018-03-06 | |
| 2014-12-31 | $84.00K 10-K · filed 2017-03-13 |